Fig. 6: The changes of JAK1/STAT3 signaling pathway protein in tumor tissues among the groups.
From: Bifidobacterium boosts anti-PD-1 effectiveness through JAK pathway in hepatocellular carcinoma
Scores of JAK1(a–c), p-JAK1(d–f), STAT3(g–i), and p-STAT3(j–l) in tissue sections of different groups. The date was presented as mean with 95% CI. n = 3 per group. One-way ANOVA test was used.
